BioSpace News Archive

Press Releases

Akeso Announces First Patient Dosed in Registrational Phase II Study of TIGIT/TGF-β Bifunctional Antibody Fusion Protein AK130 Combined with Ivonescimab for Advanced Pancreatic Cancer

September 22, 2025
·
5 min read
Press Releases

ADC Innovator Myricx Bio Appoints Boston-based Mohit Rawat as CEO and Expands Team in US and UK

September 22, 2025
·
7 min read
Press Releases

BetaGlue Therapeutics Announces the Appointment of Alexis Peyroles as New Chief Executive Officer

September 22, 2025
·
2 min read
Press Releases

C4X Discovery announces selection of a once-daily development candidate from its α4β7 inhibitor programme

September 22, 2025
·
4 min read
Press Releases

Positive phase III results show Roche’s giredestrant significantly improved progression-free survival in ER-positive advanced breast cancer

September 22, 2025
·
12 min read
Press Releases

Ipsen’s LANTIC Phase II in aesthetics delivers a first-in-class, differentiated long-acting clinical profile for IPN10200, enabling the initiation of Phase III

September 22, 2025
·
9 min read
Press Releases

Press Release: Update on the US regulatory review of tolebrutinib in non-relapsing, secondary progressive multiple sclerosis

September 22, 2025
·
9 min read
Press Releases

Two International Proxy Advisory Firms Support the Governance Project Proposed by OSE Immunotherapeutics at the September 30th General Meeting

September 22, 2025
·
5 min read
Press Releases

Global expansion of Idorsia’s QUVIVIQ continues as Simcere launches in China

September 22, 2025
·
6 min read
Press Releases

CROSSJECT Secures Additional BARDA Funding for the Progressive Developmental and FDA Authorization of the ZEPIZURE® (ZENEO® Midazolam)

September 22, 2025
·
2 min read